Sernova (TSE:SVA) Hits New 12-Month Low – Should You Sell?

Sernova Corp. (TSE:SVAGet Free Report)’s share price hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as C$0.18 and last traded at C$0.18, with a volume of 47943 shares changing hands. The stock had previously closed at C$0.19.

Sernova Stock Down 5.4 %

The stock has a market capitalization of C$58.89 million, a P/E ratio of -1.69 and a beta of 1.35. The company has a debt-to-equity ratio of -4.40, a current ratio of 0.32 and a quick ratio of 18.11. The firm has a 50-day simple moving average of C$0.21 and a 200 day simple moving average of C$0.23.

About Sernova

(Get Free Report)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.

Recommended Stories

Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.